Medline Inc.

MDLN | NASDAQ

Price Alert Chart Builder DCF Calculator

$32.12

+$0.12 (+0.37%)

At close: Oct 30, 2026, 4:00 PM ET

$32.12

$0.00 (0.00%)

Pre-market: Nov 2, 2026, 4:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.37%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

48.4

-0.6 pts

Fundamentals Average

Market Sentiment Neutral

Moat Narrow

Sector Rank #317/1028 (Top 31%)

Full Analysis

Key Statistics

Market Data

Market Cap $28.18B

1D Range

31.37 32.29

52W Range

31.37 49.99

Valuation (TTM)

PE 37.35

PB 2.44

EV/EBITDA 14.97

Valuation (NTM)

Forward PE 22.31

Forward PEG 1.57

Price Target $44.20

Cash Flow

FCF Yield 7.2%

SBC Adj. FCF Yield 7.1%

SBC Impact -1.4%

Margins

Gross Margin 25.0%

Operating Margin 6.1%

FCF Margin 6.8%

Growth (CAGR)

Revenue 3Y | 5Y 9.8% | N/A

Dil EPS 3Y | 5Y 52.1% | N/A

FCF 3Y | 5Y -3.8% | N/A

Returns

ROA 1.8%

ROE 5.5%

ROIC 4.0%

Financial Health

Net Debt

$9.9B

Current Ratio 4.33

Interest Coverage 2.50

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices,...

Sector Healthcare

Industry Medical - Instruments & Supplies

Employees 45,000

IPO Date Dec 17, 2025

Website www.medline.com

Fiscal Year January - December

Full Company Profile

Latest News

3 days ago · globenewswire.com

MDLN Stock Market Alert: Medline Under Investigation for Potential Securities Fraud Over Product Quality Issues – Contact BFA Law if You Lost Money

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

5 days ago · globenewswire.com

$MDLN Stock Market Alert: Medline Investigated for Securities Fraud after Product Quality Issues Lead to 13% Stock Drop – Contact BFA Law if You Lost Money

NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

14 days ago · globenewswire.com

MDLN Investigation Reminder: Medline Investors that Lost Money after the 13% Stock Drop are Notified to Contact BFA Law

NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

18 days ago · prnewswire.com

Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.

State-of-the-art facility planned to reinforce Medline's supply chain resilience in Michigan NORTHFIELD, Ill., Oct. 15, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, has announced plans to open a new distribution center in Van Buren Township, Mich.

21 days ago · prnewswire.com

Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care

Combines real-time inventory tracking with PointClickCare® integration to reduce manual work and improve supply visibility NORTHFIELD, Ill., Oct. 12, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) today announced the launch of an enhanced version of TrackPoint™, its online inventory management and patient item usage solution designed to help long-term care and inpatient hospice providers more easily track supplies from Medline, capture patient-level usage and gain visibility into inventory across locations.

27 days ago · globenewswire.com

Medline to report third quarter 2026 results on November 4, 2026

NORTHFIELD, Ill., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report third quarter 2026 financial results on Wednesday, November 4, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results.

28 days ago · globenewswire.com

MDLN Investigation Notification: Medline is Under Investigation for Securities Fraud over Product Quality Issues – Contact BFA Law if You Suffered Losses

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

1 month ago · globenewswire.com

$MDLN Stock Notification: Medline Inc. is Being Investigated for Securities Fraud after Product Quality Issues Disclosed – Investors are Alerted to Contact BFA Law

NEW YORK, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops.

2 months ago · globenewswire.com

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm

Medline Inc. (NASDAQ: MDLN) shareholders should email fletcher@fmoorelaw.com NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- What is the Investigation About?